SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 23rd, 2025 • Flora Growth Corp. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 23rd, 2025 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of September 19, 2025, is by and between Flora Growth Corp, a corporation organized under the laws of the Province of Ontario, Canada (the "Company"), and each investor identified on the signature pages hereto (each, including its successors and assigns, the "Investors" and together with the Company, the "Parties" and each a "Party"). Capitalized terms used and not otherwise defined herein that are defined in the Notes (as defined below) shall have the meanings given to such terms in the Notes.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 23rd, 2025 • Flora Growth Corp. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 23rd, 2025 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of September 19, 2025, between Flora Growth Corp., an Ontario corporation (the "Company"), and each investor identified on the signature pages hereto (each, including its successors and assigns, an "Investor" and collectively, the "Investors"). Subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the "1933 Act"), and/or Rule 506(b) promulgated thereunder or Rule 903 of Regulation S under the 1933 Act, the Company desires to issue and sell to each Investor, and each Investor, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 23rd, 2025 • Flora Growth Corp. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 23rd, 2025 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of September 19, 2025, between Flora Growth Corp., an Ontario corporation (the "Company"), and each investor identified on the signature pages hereto (each, including its successors and assigns, an "Investor" and collectively, the "Investors"). Subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the "1933 Act"), and/or Rule 506(b) promulgated thereunder or Rule 903 of Regulation S under the 1933 Act, the Company desires to issue and sell to each Investor, and each Investor, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 23rd, 2025 • Flora Growth Corp. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 23rd, 2025 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 22, 2025, is by and between Flora Growth Corp, a corporation organized under the laws of the Province of Ontario, Canada (the “Company”), and each Zero Gravity Labs Inc. (the “Investor” and together with the Company, the “Parties” and each a “Party”). Capitalized terms used and not otherwise defined herein that are defined in the Note (as defined below) shall have the meanings given to such terms in the Note.